{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:59:12Z","timestamp":1775782752135,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2003,10,2]],"date-time":"2003-10-02T00:00:00Z","timestamp":1065052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,10,2]],"date-time":"2003-10-02T00:00:00Z","timestamp":1065052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,12,1]]},"DOI":"10.1038\/sj.leu.2403161","type":"journal-article","created":{"date-parts":[[2003,10,2]],"date-time":"2003-10-02T13:18:13Z","timestamp":1065100693000},"page":"2542-2544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome"],"prefix":"10.1038","volume":"17","author":[{"given":"M","family":"Hummel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Buchheidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Hofheinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Hehlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,10,2]]},"reference":[{"key":"BF2403161_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1200\/JCO.2001.19.3.697","volume":"19","author":"CH Pui","year":"2001","unstructured":"Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 2001; 19: 697\u2013704.","journal-title":"J Clin Oncol"},{"key":"BF2403161_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJM197008132830708","volume":"283","author":"PR Band","year":"1970","unstructured":"Band PR, Silverberg DS, Henderson JF, Ulan RA, Wensel RH, Banerjee TK et al. Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. N Engl J Med 1970; 283: 354\u2013357.","journal-title":"N Engl J Med"},{"key":"BF2403161_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/0026-0495(72)90124-2","volume":"21","author":"A Ablin","year":"1972","unstructured":"Ablin A, Stephens BG, Hirata T, Wilson K, Williams HE . Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinol. Metabolism 1972; 21: 771\u2013778.","journal-title":"Metabolism"},{"key":"BF2403161_CR4","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","volume":"97","author":"SC Goldman","year":"2001","unstructured":"Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001; 97: 2998\u20133003.","journal-title":"Blood"},{"key":"BF2403161_CR5","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/sj.leu.2402235","volume":"15","author":"CH Pui","year":"2001","unstructured":"Pui CH, Jeha S, Irwin D, Camitta B . Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial. Leukemia 2001; 15: 1505\u20131509.","journal-title":"Leukemia"},{"key":"BF2403161_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00520-002-0435-3","volume":"11","author":"L Annemans","year":"2003","unstructured":"Annemans L, Moeremans K, Lamotte M, Garcia CJ, van den BH, Myint H et al. Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients. Support Care Cancer 2003; 11: 249\u2013257.","journal-title":"Support Care Cancer"},{"key":"BF2403161_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/sj.leu.2402847","volume":"17","author":"PM Navolanic","year":"2003","unstructured":"Navolanic PM, Pui CH, Larson RA, Bishop MR, Pearce TE, Cairo MS et al. Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002. Leukemia 2003; 17: 499\u2013514.","journal-title":"Leukemia"},{"issue":"4, Suppl. 10","key":"BF2403161_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1053\/shem.2001.29018","volume":"38","author":"CH Pui","year":"2001","unstructured":"Pui CH . Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience. Semin Hematol 2001; 38 (4, Suppl. 10): 13\u201321.","journal-title":"Semin Hematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403161","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:47:14Z","timestamp":1648777634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,2]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12,1]]}},"alternative-id":["BF2403161"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403161","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,2]]},"assertion":[{"value":"21 July 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}